‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

3 months ago 3
ARTICLE AD BOX
Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs
Read Entire Article
  1. Homepage
  2. category-label-
  3. ‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

Related

Research firm declares ‘end of the AI trade as we know it’ — and Asian tech stocks reflect the shift

Research firm declares ‘end of the AI trade as we know it’ —...

18 minutes ago 0
Wall Street bets Democratic sweep will empower moderates in Washington

Wall Street bets Democratic sweep will empower moderates in ...

40 minutes ago 0
A prolonged war in Iran is the market’s real ‘black swan,’ says this strategist

A prolonged war in Iran is the market’s real ‘black swan,’ s...

1 hour ago 0
RIGHT SIDEBAR TOP AD

Trending

1. alan jones
2. météo
3. nc lottery
4. crude oil prices
5. coinbase
6. power
7. guy fawkes day
8. dianna russini
9. mccaysville ga
10. clima de hoy

Popular

Netflix investors are getting squeamish as Amazon makes inroads in the battle for streaming dominance

Netflix investors are getting squeamish as Amazon makes inro...

5 months ago 16
Some singles now expect their dates to pay for their Ubers while gas prices are so high

Some singles now expect their dates to pay for their Ubers w...

5 months ago 15
‘This is not a flash in the pan’ — why value stocks are beating growth by such a wide margin

‘This is not a flash in the pan’ — why value stocks are beat...

4 months ago 15
Here’s how SpaceX is pitching its IPO to everyday investors

Here’s how SpaceX is pitching its IPO to everyday investors

5 months ago 14
Jane Street Plans New Data Center as Compute Power Runs Scarce

Jane Street Plans New Data Center as Compute Power Runs Scar...

5 months ago 13
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexus Financial News 2026. All rights are reserved